Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:2013:204237.
doi: 10.1155/2013/204237. Epub 2013 Jun 26.

Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents

Claudia Spampinato  1 , Darío Leonardi
Affiliations
Review

Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents

Claudia Spampinato et al. Biomed Res Int. 2013.

Abstract

The genus Candida includes about 200 different species, but only a few species are human opportunistic pathogens and cause infections when the host becomes debilitated or immunocompromised. Candida infections can be superficial or invasive. Superficial infections often affect the skin or mucous membranes and can be treated successfully with topical antifungal drugs. However, invasive fungal infections are often life-threatening, probably due to inefficient diagnostic methods and inappropriate initial antifungal therapies. Here, we briefly review our current knowledge of pathogenic species of the genus Candida and yeast infection causes and then focus on current antifungal drugs and resistance mechanisms. An overview of new therapeutic alternatives for the treatment of Candida infections is also provided.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Primary targets and mode of action of several antifungal agents.
Figure 2
Figure 2
Chemical structures of three agents with actual promise: E1210 (a), albaconazole (b), and isavuconazole (c).
See this image and copyright information in PMC

References

    1. Jackson BE, Wilhelmus KR, Mitchell BM. Genetically regulated filamentation contributes to Candida albicans virulence during corneal infection. Microbial Pathogenesis. 2007;42(2-3):88–93. - PMC - PubMed
    1. Wu TG, Mitchell BM, Carothers TS, et al. Molecular analysis of the pediatric ocular surface for fungi. Current Eye Research. 2003;26(1):33–36. - PubMed
    1. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clinical Microbiology Reviews. 2010;23(2):253–273. - PMC - PubMed
    1. Rosenbach A, Dignard D, Pierce JV, Whiteway M, Kumamoto CA. Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryotic Cell. 2010;9(7):1075–1086. - PMC - PubMed
    1. Naglik JR, Moyes DL, Wächtler B, Hube B. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes and Infection. 2011;13(12-13):963–976. - PMC - PubMed

Publication types

Substances